CURRICULUM VITAE MAURIZIO BONATI

ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI Laboratorio per la Salute Materno Infantile Dipartimento di Salute Pubblica Via Giuseppe La Masa, 19-20156 Milano MI - Italy - www.marionegri.it tel +39 02 39014.1 - fax +39 02 354.6277 - mnegri@marionegri.it CURRICULUM VITAE MAURIZIO BONATI Marzo 2016 IRCCS Decreto Ministeriale 18 gennaio 2013 (Gazzetta Uff. N. 34 del 9/2/2013) I CONTRIBUTI PER LA RICERCA VERSATI ALL'ISTITUTO SONO FISCALMENTE DEDUCIBILI DAL REDDITO (Gazzetta Uff. N. 179 del 3/8/2011) FONDAZIONE PER RICERCHE ERETTA IN ENTE MORALE, D.P.R. 361 DEL 5/4/1961 - REGISTRO PERSONE GIURIDICHE PREFETTURA MILANO N.227 CONTO CORRENTE POST. N.58337205 - COD. FISC. E PARTITA IVA 03254210150 - ANAGRAFE NAZIONALE RICERCHE COD.G1690099 RECOGNIZED AS A TAX EXEMPT ORGANIZATION UNDER SECTION 501 (c)(3) OF THE USA INTERNAL REVENUE CODE-TAX I.D. No.: 98-6000957 Sistema di gestione qualità certificato da Certiquality UNI EN ISO 9001:2008, progettazione ed erogazione di corsi di formazione specialistica nell ambito della biologia e della medicina

Curriculum Vitae Europass INFORMAZIONI PERSONALI Nome Indirizzo Telefono BONATI MAURIZIO IRCCS - ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI VIA GIUSEPPE LA MASA, 19 20156 MILANO (MI) 02/39014511 segreteria Fax 02/3550924 maurizio.bonati@marionegri.it E-mail Nazionalità Italiana Data di nascita 15 LUGLIO 1954 OCCUPAZIONE DESIDERATA/ SETTORE PROFESSIONALE Epidemiologia clinica, farmacologia clinica/ salute pubblica, pediatra, neuropsichiatria ESPERIENZA LAVORATIVA Date 1973-1977 Ricercatore presso l Istituto di Ricerche Farmacologiche Mario Negri, Milano Laboratorio di Neurochimica. 1977-1985 Assistente ricercatore presso l Istituto di Ricerche Farmacologiche Mario Negri, Milano Laboratorio di Farmacologia Clinica 1986-1993 Capo dell Unità di Farmacologia Clinica Perinatale presso l Istituto di Ricerche Farmacologiche Mario Negri, Milano Referente OMS per il Gruppo di Ricerca sull Utilizzo dei Farmaci (in particolare, l uso dei farmaci in gravidanza ed in età pediatrica) 1987-1992 Coordinatore dello Studio Cooperativo Internazionale sull uso di farmaci in gravidanza, sotto l auspicio della OMS ed il supporto della CEE 1989-2009 Responsabile del Centro di Informazione sul Farmaco e la Salute, CIFS 1992-1993 Co-Editor di The Kangaroo dal 1993 Capo del Laboratorio per la Salute Materno-Infantile Istituto di Ricerche Farmacologiche Mario Negri dal 1997 Docente ai Corsi di Formazione Professionale della Regione Lombardia. dal 2000 Docente al Corso di PhD (Dottorato di Ricerca nell ambito di un accordo siglato con la Open University di Milton Keines, UK). Membro Permanente della Giuria Internazionale del Premio Colsubsidio de Investigación en Pediatria, Colombia. 2000 2005

Coordinatore dello Studio Cooperativo Internazionale per la creazione di un registro della sperimentazione farmacologia clinica pediatrica (DEC-net), con il supporto della UE (5 th Framework Programme) 2001-2008 Direttore dello Stage annuale in Cooperazione e Salute Pubblica; Master in Analisi e Gestione di Progetti di Sviluppo dell Università degli Studi di Milano (Facoltà di Scienze e Politiche). dal 2001 Membro della Commissione Tecnica per l elaborazione e aggiornamento del Prontuario Terapeutico Regionale (P.T.R.) della Regione Autonoma Valle D Aosta dal 2002 Direttore di Redazione della rivista Ricerca & Pratica 2003-2005 Docente al corso annuale europeo Evaluation of medicinal products in children promosso da ESDPPP e Eudipharm dal 2003 Docente Titolare della Scuola Di Specializzazione in Pediatria - Università di Milano Bicocca dal 2004-2008 Coordinatore del Gruppo di Lavoro Farmaci e Bambini AIFA dal 2004 Membro del Comitato Scientifico del Registro Nazionale ADHD dal 2005 Membro della Commissione Tecnico-Scientifica per la programmazione e verifica delle vaccinazioni - Regione Lombardia 2006-2009 Esperto del Consiglio Superiore di Sanità 2007-2009 Membro della Commissione Nazionale Vaccini dal 2008 Capo del Dipartimento di Salute Pubblica Istituto di Ricerche Farmacologiche Mario Negri 2010-2011 Docente titolare della Scuola di Specializzazione in Neuropsichiatria Infantile Università degli Studi di Pavia. 2010-2014 Coordinatore del Progetto Collaborativo Internazionale Coordinating resources to assess and improve health status of migrants from Latin America, con il support della UE (7 th Framework Programme). Official H index (Web of Science, November 2015): 33.0 Nome e indirizzo del datore di lavoro Tipo di azienda o settore Tipo di impiego IRCCS - Istituto di Ricerche Farmacologiche Mario Negri Via G. La Masa, 19 20156 Milano - Italia Una fondazione privata al servizio degli ammalati - Ricerca clinica e territoriale Capo del Dipartimento di Salute Pubblica e del Laboratorio per la Salute Materno-Infantile

Principali mansioni e responsabilità Monitoraggio e valutazione epidemiologica dell utilizzo di farmaci e degli effetti dei farmaci e dei vaccini in età pediatrica e durante la gravidanza. Ricerca metodologica nell ambito dell assistenza ospedaliera e delle cure primarie pediatriche. Promozione e produzione di informazioni sanitarie nella comunità. Epidemiologia delle cure pediatriche e perinatali. Collaborazione (anche con Organizzazioni Non Governative) a progetti sanitari in Paesi con scarse risorse. Docenza a corsi, master e iniziative di formazione sociosanitaria nazionali e internazionali. Consulenza per l Organizzazione Mondiale della Sanità (OMS), per l Agenzia Europea del Medicamento (EMEA) e per l Agenzia Italiana del Farmaco (AIFA). Collaborazione redazionale a riviste scientifiche nazionali e internazionali. (Membro della redazione di: European Journal of Clinical Pharmacology; Paediatric & Perinatal Drug Therapy; Pediatric Health; Pediatria di São Paulo; Saludarte; Dialogo sui Farmaci; Disturbi d Attenzione e Iperattività; Quaderni ACP; Vaccine). ISTRUZIONE E FORMAZIONE Date (da a) Nome e tipo di istituto di istruzione o formazione Principali materie / abilità professionali oggetto dello studio Qualifica conseguita Livello nella classificazione nazionale (se pertinente) dottore in Medicina, laureato presso l Università di Milano CAPACITÀ E COMPETENZE PERSONALI Madrelingua(e) Altra(e) lingua(e) Autovalutazione Livello europeo (*) Lingua Lingua Lingua Italiano 1 Inglese 2 Spagnolo Comprensione Parlato Scritto Ascolto Lettura Interazione orale Ascolto Lettura 1 C 1 C 1 C 1 C 1 C 2 C 2 B 2 B 2 B 2 A CAPACITÀ E COMPETENZE RELAZIONALI Vivere e lavorare con altre persone, in ambiente multiculturale, occupando posti in cui la comunicazione è importante e in situazioni in cui è essenziale lavorare in squadra (ad es. cultura e sport), ecc. CAPACITÀ E COMPETENZE ORGANIZZATIVE Ad es. coordinamento e amministrazione di persone, progetti, bilanci; sul posto di lavoro, in attività di volontariato (ad es. cultura e sport), a casa, ecc. TUTOR DI STUDENTI E RICERCATORI. CAPACITÀ DI RELAZIONARE E TENERE LEZIONI A PERSONALE SCIENTIFICO E NON. COORDINATORE E MEMBRO DI COMMISSIONI E GRUPPI D LAVORO LOCALI, NAZIONALI E INTERNAZIONALI ORGANIZZATORE DI CONVEGNI, CORSI E INIZIATIVE SCIENTIFICHE NAZIONALI ED INTERNAZIONALI. COORDINAMENTO E AMMINISTRAZIONE DI PROGETTI SOCIOSANITARI, LAVORI NAZIONALI E INTERNAZIONALI, IN PARTICOLARE NELL AMBITO DELLA SALUTE DELL ETA EVOLUTIVA. ATTIVITA DI VOLONTARIATO CON ASSOCIAZIONI NO PROFIT. HO TUTTE LE NOZIONI TECNICHE E PROFESSIONALI PER PIANIFICARE LE RICERCHE CHE COORDINO. GESTIONE ED ELABORAZIONE DATI. STESURA DI RAPPORTI DI TRASFERIMENTO DI CONOSCENZE.

CAPACITÀ E COMPETENZE TECNICHE Con computer, attrezzature specifiche, macchinari, ecc. ALLEGATI Il sottoscritto è a conoscenza che, ai sensi dell art. 26 della legge 15/68, le dichiarazioni mendaci, la falsità negli atti e l uso di atti falsi sono puniti ai sensi del codice penale e delle leggi speciali. Inoltre, il sottoscritto autorizza al trattamento dei dati personali, secondo quanto previsto dalla Legge 196/03. SKETCH CV Maurizio Bonati si è laureato in Medicina e Chirurgia presso l Università degli Studi di Milano. Aree di interesse: monitoraggio e valutazione epidemiologica dell utilizzo e degli effetti dei farmaci e dei vaccini in età pediatrica e in gravidanza; ricerca metodologica nell ambito dell assistenza ospedaliera e delle cure primarie pediatriche; promozione e produzione di informazioni sanitarie nella comunità; epidemiologia delle cure pediatriche e perinatali. Ruoli attuali e passati in Istituto e in organizzazioni esterne: 1973-77 Ricercatore presso l IRFMN, Laboratorio di Neurochimica; 1977-85 assistente ricercatore presso l IRFMN, Laboratorio di Farmacologia Clinica; 1986-93 capo dell Unità di Farmacologia Clinica Perinatale; membro del Gruppo di Ricerca sull Utilizzo dei Farmaci (gravidanza, pediatria e allattamento) dell OMS; 1987-92 coordinatore dello Studio Cooperativo Internazionale sull uso di farmaci in gravidanza, sotto l auspicio della OMS ed il supporto della CEE; 2000-05 coordinatore dello Studio Cooperativo Europeo: Registro Europeo degli Studi Clinici Pediatrici (DEC-net; 5 th Framework Programme); dal 1989 Responsabile del Centro di Informazione sul Farmaco e la Salute, CIFS; dal 1993 capo del Laboratorio per la Salute Materno-Infantile all IRFMN; dal 1997 docente ai Corsi di Formazione Professionale della Regione Lombardia; dal 2000 direttore dello Stage annuale in Cooperazione e Salute Pubblica - Master in Analisi e Gestione di Progetti di Sviluppo dell Università degli Studi di Milano; dal 2002 direttore di redazione della rivista Ricerca & Pratica; dal 2003 docente titolare della Scuola di Specializzazione in Pediatria dell Università di Milano Bicocca; Docente titolare della Scuola di Specializzazione in Neuropsichiatria Infantile Università degli Studi di Pavia; docente al corso annuale europeo Evaluation of medicinal products in children promosso da ESDPPP e Eudipharm; dal 2008 capo del Dipartimento di Salute Pubblica; dal 2010 Coordinatore del Progetto Collaborativo Internazionale Coordinating resources to assess and improve health status of migrants from Latin America, con il supporto della UE (7 th Framework Programme). [Official H index (Web of Science, November 2015): 33.0] Milano, marzo 2016 Dr. Maurizio Bonati

Articoli Scientifici 1974 Algeri S, Bonati M, Ponzio F, Turner AJ. Dihydropteridine reductase: enzyme characteristics, regional distribution and ontogenic development. Br J Pharmacol 1974;52:448. 1977 Algeri S, Bonati M, Brunello N, Ponzio F. Dihydropterine reductase and tyrosine hydroxylase activities in rat brain during development and senescence study. Brain Res 1977;132:569-574. 1978 Altamura AC, Bonati M, Brunello N, Giordano PL, Algeri S. The activity of some neurotransmittersynthetizing enzymes in experimental cobalt epilepsy. Neurosci Lett 1978;7:83-87. Latini R, Assael BM, Bonati M, Caccamo ML, Gerna M, Mandelli M, Marini A, Sereni F, Tognoni G. Kinetics and efficacy of theophylline in the treatment of apnea in the premature newborn. Eur J Clin Pharmacol 1978;13:203-207. Latini R, Bonati M, Castelli D, Garattini S. Dose-dependent kinetics of caffeine in rats. Toxicol Lett 1978;2:267-270. 1979 Bonati M, Castelli D, Latini R, Garattini S. Comparison of gas-liquid chromatography with nitrogenphosphorus selective detection and high-performance liquid chromatography methods for caffeine determination in plasma and tissues. J Chromatogr 1979;164:109-113. 1980 Bonati M, Latini R, Marzi E, Cantoni R, Belvedere G. [2-14C]-Caffeine metabolism in control and 2- methylcholanthrene induced rat liver microsomes by high presure liquid chromatography. Toxicol Lett 1980;7:1-7. Latini R, Bonati M, Marzi E, Tacconi M.T, Sadurska B, Bizzi A. Caffeine disposition and effects in young and one year old rats. J Pharm Pharmacol 1980;32:596-599. Tognoni G, Bellantuono C, Bonati M, D'Incalci M, Gerna M, Latini R, Mandelli M, Porro M.G, Riva E. Clinical relevance of pharmacokinetics. Clin Pharmacokinet 1980;5:105-136. 1981 Bonati M, Latini R, Marra G, Assael B.M, Parini R. Theophylline metabolism during the first month of life and development. Pediatr Res 1981;15:304-308. Bonati M, Latini R, Marra G, Assael B.M, Parini R. Theophylline distribution in the premature neonate. Dev Pharmacol Ther 1981;3:65-73. Latini R, Bonati M, Marzi E, Garattini S. Urinary excretion of an uracilic metabolite from caffeine by rat, monkey and man. Toxicol Lett 1981;7:267-272. 1982 Bonati M, Kanto J, Tognoni G. Clinical pharmacokinetics of cerebrospinal fluid. Clin Pharmacokinet 1982;7:312-335. Bonati M, Latini R, Galletti F, Young JF, Tognoni G, Garattini S. Caffeine disposition after oral doses. Clin Pharmacol Ther 1982;32:98-106.

1983 Gaspari F, Celardo A, Bonati M. Apparent dissociation constants of some possible uracil metabolites of methylxanthines. Anal Lett 1983;16:167-180. Bonati M, Bortolotti A, Jiritano L, Latini R, Garattini S. Disposition of 6-amino-5(Nmethylformilamino) 1,3-dimethyluracil, one of the primary metabolites of caffeine, in the rat. Drug Metab Dispos 1983;11:509-511. Bonati M, D'Aranno V, Galletti F, Fortunati M.T, Tognoni G. Acute overdosage of amiodarone in a suicide attempt. J Toxicol Clin Toxicol 1983;20:181-186. Bonati M, Galletti F, Volpi A, Cumetti C, Rumolo R, Tognoni G. Amiodarone in patients on longterms dialysis. New Engl J Med 1983;308:906. Peri G, Polentarutti B, Filippeschi S, Malfiore C, Amato G, Pepe S, Bonati M, Garattini S, Mantovani A. In vivo and in vitro cytotoxicity of possible uracil metabolites of methylxanthines. Toxicol Lett 1983;18:133-140. 1984 Bonati M, Tognoni G. Has clinical pharmacology lost its way? Lancet 1984;1:556-558. Bonati M, Celardo A, Galletti F, Latini R, Tursi F, Belvedere G. Kinetics of caffeine metabolism in control and 3-methylcholanthrene induced rat liver microsomes. Toxicol Lett 1984;21:53-58. Airoldi L, Macrì A, Bonfanti M, Bonati M, Fanelli R. Kinetics and biovailability of N- nitrosodiethanolamine after intravenous and cutaneous administration to rats. Fd Chem Toxic 1984;22:133-138. Bonati M, Latini R, Sadurska B, Riva E, Galletti F, Borzelleca JE, Tarka S.M, Arnaud MJ, Garattini S. I: Kinetics and metabolism of theobromine in male rats. Toxicology 1984;30:327-341. Latini R, Bonati M, Gaspari F, Traina GL, Jiritano L, Bortolotti A, Borzelleca JF, Tarka SM, Arnaud MJ, Garattini S. II. Kinetics and metabolism of theobromine in male and female non pregnat and pregnant rabbits. Toxicology 1984;30:343-354. Bonati M, Gaspari F, Benfenati E, Neyroz P, D'Aranno E, Galletti F, Tognoni G. Physicochemical and analytical characteristics of amiodarone. J Pharm Sci 1984;73:829-831. Cerletti C, Bonati M, Del Maschio A, Galletti F, Dejana E, Tognoni G, De Gaetano G. Plasma levels of salycylate and aspirin in healthy subjects relevance to drug interaction on platelet function. J Lab Clin Med 1984;103:870-877. Traina GL, Bonati M. Pharmacokinetics of teicoplanin in man after intravenous administration. J Pharmacokinet Biop 1984;12:119-128. Bonati M, Latini R, Tognoni G, Young JF, Garattini S. Interspecies comparison of in vivo caffeine pharmacokinetics in man, monkey, rabbit, rat and mouse. Drug Metab Rev 1984;15: 1355-1383. 1985 Bortolotti A, Jiritano L, Bonati M. Pharmacokinetics of paraxanthine, one of the primary metabolites of caffeine, in the rat. Drug Metab Dispos 1985;13:227-231. Neyroz P, Bonati M. In vitro amiodarone protein binding and its interaction with warfarin. Experientia 1985;4:361-363.

Traina GL, Bonati M. Pharmacokinetics of theobromine and its metabolites in rabbits. J Pharmacokinet Biop 1985;13:41-53. Bonati M, Gaspari F, Traina GL, Tognoni G. Therapeutic drug monitoring. J Clin Immunoassay 1985;8:169-172. Gaspari F, Marraro G, Penna GF, Valsecchi R, Bonati M. Elimination kinetics of thiopentone in mothers and their newborn infants. Eur J Clin Pharmacol 1985;28:321-325. Snidero M, Traina GL, Bonati M. Ambulatory therapeutic digoxin monitoring. Drug Intell Clin Pharm 1985;19:660-661. Bortolotti A, Bonati M. Pharmacokinetics of theobromine in male rats in different traumatic conditions. Res Commun Chem Pathol Pharmacol 1985;50:35-44. Bonati M, Castelli D, Leone N, Perucca E, Tognoni G. Antiepileptic drug monitoring. Drug Intell Clin Pharm 1985;19:913-915. Jiritano L, Bortolotti A, Gaspari F, Bonati M. Caffeine disposition after oral administration to pregnant rats. Xenobiotica 1985;15:1045-1051. Bonati M, Jiritano L, Bortolotti A, Gaspari F, Filippeschi S, Puigdemont A, Garattini S. Caffeine distribution in acute toxic response among inbred mice. Toxicol Lett 1985;29:25-31. Tognoni G, Bandera L, Bonati M, Franzosi MG, Kasilo O. An action program for clinical pharmacology. Revista de Farmacologia Clinica y Experimental 1985;2:99-102. Celardo A, Traina GL, Jankowski A, Bonati M. Pharmacokinetics of theophylline and its metabolites in rabbits. Eur J Drug Metab Pharmacokinet 1985;10:279-288. 1986 Bonati M, Traina GL, Colombo F, Tognoni G. Digoxin serum requests. Lancet 1986;i:623-624. Jiritano L, Bortolotti A, Bonati M. The effect of chronic oral ketoconazole on in vivo drug metabolism in the rat. Res Commun Chem Pathol Pharmacol 1986;54:173-180. Tognoni G, Bonati M. Second-generation clinical pharmacology. Lancet 1986;ii:1028-1029. Traina GL, Celardo A, Arboix M, Bonati M. Experimental model for pharmacokinetic studies during continuous peritoneal dialysis in the rabbit. J Pharmacol Methods 1986;15:133-142. Traina GL, Gentile MG, Fellin G, Rosina R, Cavenaghi L, Buniva G, Bonati M. Pharmacokinetics of teicoplanin in patients on continuous ambulatory peritoneal dialysis. Eur J Clin Pharmacol 1986;31:501-504. 1987 Gaspari F, Bonati M. Quantitative relationships between physicochemical characteristics and pharmacokinetics of caffeine and its metabolites in the rat. J Pharm Pharmacol 1987;39:252-260. Bonati M, Traina GL, Villa G, Salvadeo A, Gentile M.G, Fellin G, Rosina R, Cavenaghi L, Buniva G. Teicoplanin pharmacokinetics in patients with chronic renal failure. Clin Pharmacokinet 1987;12:292-301. Gaspari F, Viganò G, Orisio S, Bonati M, Livio M, Remuzzi G. Aspirin prolongs bleeding time in uremia by a mechanism distinct from platelet cyclooxygenase inhibition. J Clin Invest 1987;79:1788-1797.

Celardo A, Traina GL, Arboix M, Puigdemont A, Bonati M. Pharmacokinetic and pharmacodynamic modelling of atenolol in rabbits mantained on continuous peritoneal dyalisis. Eur J Drug Metab Pharmacokinet 1987;12:41-48. Guaitani A, Abbruzzi R, Bastone A, Bianchi M, Bonati M, Catalani R, Latini R, Pantarotto C, Szczawinska K. Metabolism of caffeine to 6-amino-5-[N-Methylformylamino]-1,3-dimethyluracil in the isolated, perfused liver from control, phenobarbital-, ß-naphthoflavone- and 3-methylcholanthrenepretreated rats. Toxicol Lett 1987;38:55-66. Farina M.L, Bonati M, Iapichino G, Pesenti A, Procaccio F, Boselli L, Langer M, Graziina A, Tognoni G. Clinical Pharmacological and Therapeutic Considerations in General Intensive Care. Drugs 1987;34:662-694. Sangalli L, Bonati M. Reversed-phase high performance liquid chromatography determination of cyclosporine in human blood. Ther Drug Monit 1987;9:353-357. 1988 Bonati M, Brambilla C, Colombo F, Tognoni G, Italian Collaborative Group on Preterm Delivery. Early neonatal drug utilization in preterm newborns in neonatal intensive care units. Dev Pharmacol Ther 1988;11:1-7. Bonati M, Traina GL, Rosina R, Buniva G. Pharmacokinetics of a single intravenous dose of teicoplanin in subjects with various degrees of renal impairment. J Antimicrob Chemoth 1988;21(Suppl. A):29-37. Bonati M, Garattini G. Pharmacokinetics of caffeine. ISI Atlas of Science. Pharmacology 1988;1:33-39. Bonati M, Traina GL, Colombo F, Gaspari F, Tognoni G, Italian Collaborative Group on Therapeutic Drug Monitoring. Italian collaborative study on the utilization of therapeutic drug monitoring in hospital departments. Ther Drug Monit 1988;10:275-279. Bonfanti M, Magagnotti C, Bonati M, Fanelli R, Airoldi L. Pharmacokinetic profile and metabolism of N-nitrosobutyl(4-hydroxybutyl)amine in rats. Cancer Res 1988;48:3666-3669. Italian Collaborative Group on Preterm Delivery, Bonati M, Brambilla C, Colombo F, Tognoni G. Prenatal and postnatal factors affecting short-term survival of very-low-birthweight infants. Eur J Pediatr 1988;147:468-471. Kasilo O, Romero M, Bonati M, Tognoni G. Information on drug use in pregnancy from the viewpoint regional drug information centre. Eur J Clin Pharmacol 1988;35:447-453. Largaespada MJ, Pistotti V, Bonati M. How accurate are bibliografic data bases? Lancet 1988;1:538. Traina GL, Gentile MG, Fellin G, Rosina R, Cavenaghi L, Buniva G, Bonati M. Pharmacokinetics of intraperitoneal teicoplanin in patients with chronic renal failure on continuous ambulatory peritoneal dialysis. Br J Clin Pharmacol 1988;25:761-765. Sangalli L, Bortolotti A, Jiritano L, Bonati M. Cyclosporine pharmacokinetics in rats and interspecies comparison in dogs, rabbits, rats, and humans. Drug Metab Dispos 1988;16:749-753. Viganò G, Gaspari F, Locatelli M, Pusineri F, Bonati M, Remuzzi G. Dose-effect and pharmacokinetics of estrogens given to correct bleeding time in uremia. Kidney Int 1988;34:853-858.

1989 Celardo A, Bortolotti A, Benfenati E, Bonati M. Measurement of vitamin E in premature infants by reversed-phase high-performance liquid chromatography. J Chromatogr 1989;490:432-438. Puigdemont A, Arboix M, Gaspari F, Bortolotti A, Bonati M. In vitro plasma protein binding of propafenone and protein profile in eight mammalian species. Res Commun Chem Pathol Pharmacol 1989;64:435-440. Pedraz JL, Calvo B, Bortolotti A, Celardo A, Bonati M. Bioavailability of intramuscular vitamin E acetate in rabbits. J Pharm Pharmacol 1989;41:415-417. Bortolotti A, Castelli D, Verotta D, Bonati M. Pharmacokinetic and pharmacodynamic modelling of metoprolol in rabbits with liver failure. Eur J Drug Metab Pharmacokinet 1989;14:145-151. Bortolotti A, Castelli D, Bonati M. Hematology and serum chemistry of adult, pregnant and newborn New Zealand rabbits (Oryctolagus cuniculus). Lab Animal Sci 1989;39:437-439. Celardo A, Passerini F, Bonati M. Placental transfer and tissue distribution of thiopental in the pregnant rat. J Pharmacokinet Biop 1989;17:425-440. 1990 Sangalli L, Bortolotti A, Passerini F, Bonati M. Placental transfer, tissue distribution, and pharmacokinetics of cyclosporine in the pregnant rabbit. Drug Metab Dispos 1990;18:102-106. Bonati M. Is it time for a registry of clinical trials in pediatrics? J Pediatr 1990;115:667-668. Bonati M, Bortolus R, Marchetti F, Romero M, Tognoni G. Drug use in pregnancy:an overview of epidemiological (drug utilization) studies. Eur J Clin Pharmacol 1990;38:325-328. Celardo A, Bonati M. Determination of thiopental measured in human blood by reversed-phase highperformance liquid chromatography. J Chromatogr 1990;527:220-225. Collaborative Group on Drug Use in Pregnancy, Bonati M, Tognoni G. Drug Use in Pregnancy: a preliminary report of the international cooperative drug utilization study. Pharm Weekbl Sci 1990;12:75-78. Gaspari F, Bonati M. Interspecies comparison of theophylline disposition. Drug Metab Rev 1990;22:145-207. Bonati M, Marraro G, Celardo A, Passerini F, Schieroni F, Spada P, Valsecchi R, De Capitani E. Thiopental efficacy in phenobarbital-resistant neonatal seizures. Dev Pharmacol Therap 1990;15:16-20. Bonati M, Marchetti F, Zullini MT, Pistotti V, Tognoni G. Adverse drug reactions in neonatal intensive care units. Adverse Drug React Acute Poisoning Rev 1990;9:103-118. Bortolotti A, Traina GL, Guaitani A, Marzi E, Latini R, Young JF, Bonati M. In- vivo and perfused liver caffeine kinetics in the rat. Res Commun Chem Pathol Pharmacol 1990;69:285-295. Bortolotti A, Traina GL, Barzago MM, Bonati M. Placental transfer and tissue distribution of vitamin E in pregnant rabbits. Biopharm Drug Dispos 1990;11:679-688. 1991 Aramayona JJ, Bonati M, Bortolotti A, Castelli D, Gaspari F, Lucchini G. Plasma protein binding of theophylline during development in the rabbit. Biol Neonate 1991;60:377-384.

Bonati M, Balocco R, Colombo A, Pistotti V. A computer filing system for drug use in a pregnancy consultation service. Comput Methods Programs Biomed 1991;35:213-217. Bonati M, Fellin G, ICGDUP. Changes in smoking and drinking behavior before and during pregnancy in Italian mothers: implications for public health intervention. Int J Epidemiol 1991;20:927-932. Bonati M, Marchetti F, Tognoni G. Management of convulsions with fever. BMJ 1991;303:1135. Bortolotti A, Corada M, Barzago MM, Celardo A, Guaitani A, Bonati M. Pharmacokinetics of theophylline in the newborn and adult rabbit. Drug Metab Dispos 1991;19:430-435. Celardo A, Dell'Elba G, Frassanito R, Benfenati E, Bonati M. Simultaneous determination of isbufylline and its major metabolites in blood and urine by reversed-phase high-performance liquid chromatography. J Chromatogr 1991;568:407-418. Clinical Pharmacology and Toxicology Study Group, Italian Society for Clinical Biochemistry. Interlaboratory variability in drug assay: A comparison of quality control data with reanalysis of routine patient samples. I: Anticonvulsant drugs and theophylline. Ther Drug Monit 1991;13:131-139. Clinical Pharmacology and Toxicology Study Group, Italian Society for Clinical Biochemistry. Interlaboratory variability in drug assay: A comparison of quality control data with reanalysis of routine patient samples. II: Digoxin. Ther Drug Monit 1991;13:140-145. Collaborative Group on Drug Use in Pregnancy (CGDUP). An international survey on drug utilization during pregnancy. Int J Risk Saf Med 1991;2:345-350. Italian Collaborative Group on Preterm Delivery. Absorption of intramuscular vitamin E in premature babies. Dev Pharmacol Therap 1991;16:13-21. Omarini D, Barzago MM, Bortolotti A, Aramayona JJ, Bonati M. Placental transfer of theophylline during in-situ perfusion in the rabbit. J Pharm Methods 1991;25:263-273. 1992 Alli C, Avanzini F, Bettelli G, Bonati M, Colombo F, Corso R, Di Tullio M, Gentile MG, Sangalli L, Taioli E, Tognoni G, et al. Feasibility of long-term low-sodium diet in mild hypertension. J Hum Hypertens 1992;6:281-286. Balocco R, Bonati M. Mefloquine prophylaxis against malaria for female travellers of childbearing age. Lancet 1992;340:309-310. Barzago MM, Bortolotti A, Omarini D, Aramayona JJ, Bonati M. Monitoring of blood gas parameters and acid-base balance of pregnant and non-pregnant rabbits (Oryctolagus cuniculus) in routine experimental conditions. Lab Anim 1992;26:73-79. Barzago MM, Omarini D, Aramayona J, Bonati M. In situ perfusion in the rabbit: effects of different umbilical flow rates on placental transfer of compounds. J Pharm Methods 1992;27:113-117. Bonati M, Balocco R. Infants with low birth weight in developing countries. The Kangaroo 1992;1:58-65. Bonati M, Marchetti F, Pistotti V, Agostini M, Bisogno G, Bussi R, Davico S, De Santis M, Forno S, Gangemi M, Merlin D, Merlo M, Murgia V, Pivetta S, Raimo F, Tamburlini G. Meta-analysis of antimicrobial prophylaxis for recurrent acute otitis media. Clin Trials and Meta-Analysis 1992;28:39-50.

Bonati M, Tognoni G. Drug Use in Pregnancy (DUP) Study. The Prescriber, Newsletter UNICEF 1992;1:2-3. Celardo A, Dell'Elba G, Bonati M. Bioavailability of oral isbufylline in rabbits. Eur J Drug Metab Pharmacokinet 1992;17:29-32. Collaborative Group on Drug Use in Pregnancy (CGDUP). An international survey on drug utilization during pregnancy (PROFILE). Int J Risk Saf Med 1992;3:49-52. Collaborative Group on Drug Use in Pregnancy (CGDUP). Medication during pregnancy: an intercontinental cooperative study. Int J Gynaecol Obstet 1992;39:185-196. Corada M, Bortolotti A, Barzago MM, Celardo A, Bonati M, Guaitani A. Pharmacokinetic profile of theophylline in isolated perfused liver of rabbits at different ages. Development of drug metabolizing activity during ontogenesis. Drug Metab Dispos 1992;20:826-831. Omarini D, Pistotti V, Bonati M. Placental perfusion: an overview of the literature. J Pharm Methods 1992;28:61-66. Omarini D, Barzago MM, Aramayona J, Bortolotti A, Lucchini G, Bonati M. Theophylline transfer across human placental cotyledon during in vitro dual perfusion. J Med 1992;23:101-116. 1993 Bortolotti A, Lucchini G, Barzago MM, Stellari F, Bonati M. Simultaneous determination of retinol, µ-tocopherol and retinyl palmitate in plasma of premature newborns by reversed-phase highperformance liquid chromatography. J Chromatogr 1993;617:313-317. Brucato A, Bonati M, Gaspari F, Colussi G, Giachetti M, Zoppi F, Ruggerone ML. Tetany and rhabdomyolysis due to surreptitious furosemide - importance of magnesium supplementation. Clin Toxicology 1993;31:341-344. Italian Collaborative Group on Preterm Delivery (ICGPD). Supplementation and plasma levels of vitamin A in premature newborns at risk for chronic lung disease. Dev Pharmacol Ther 1993;20:144-151. Marchetti F, Romero M, Bonati M, Tognoni G. The use of psychotropic drugs during pregnancy: a report of the international co-operative drug use in pregnancy (DUP) study. Eur J Clin Pharmacol 1993;45:495-501. Omarini D, Barzago MM, Bortolotti A, Lucchini G, Stellari F, Efrati S, Bonati M. Placental transfer of theophylline in an in vitro closed perfusion system by human placenta isolated lobule. Eur J Drug Metab Pharmacokinet 1993;18:369-374. Zullini MT, Bonati M. Geographical bias of prognostic scoring systems? Lancet 1993;342:1115. 1994 Barzago MM, Bortolotti A, Stellari FF, Pagani C, Marraro G, Bonati M. Respiratory and hemodynamic functions, blood-gas parameters and acid-base balance of anesthetized guine pigs. Lab Anim Sci 1994;44:648-650. Barzago MM, Omarini D, Bortolotti A, Stellari FF, Lucchini G, Efrati S, Bonati M. Mefloquine transfer during in-vitro human placenta perfusion. J Pharmacol Exp Ther 1994;269:28-31. Bonati M. Epidemiological evaluation of drug utilization in children. J Clin Pharmacol 1994;34:300-305.

1995 Bonati M, Nannini S, Addis A. Vitamin A supplementation during pregnancy in developed countries. Lancet 1995;345:736-737. Addis A, Impicciatore P, Miglio D, Da Silva CDC, Colombo F, Bonati M. Drug Use in Pregnancy and lactation: the Work of a Regional Drug Information Centre. Ann Pharmacother 1995;29:632-633. Marchetti F, Bonati M, La Gamba G, Biasini G, Tognoni G, Italian Collaborative Group on Paediatric Chronic Diseases Parental and primary care physicians' views on the management of chronic diseases: a study in Italy. Acta Paediatr 1995;84:1165-1172. Di Cerbo A, Di Paola R, Bonati M, Zingrillo M, De Filippis V, Corda D. Subgroups of graves' patients identified on the basis of biochemical activities of their immunoglobulins. J Clin Endocrinol Metab 1995;80:2785-2790. 1996 Barzago MM, Bortolotti A, Stellari FF, Diomede L, Algeri M, Efrati S, Salmona M, Bonati M. Placental transfer of valproic acid (VPA) after liposome encapsulation during in vitro human placenta perfusion. J Pharmacol Exp Ther 1996;277:79-86. Bonati M, Forte GB, De Joncheere K, Magnusson E. Drug donation to Bosnia-Hercegovina are often inappropriate. BMJ 1996;313:1011. Bonati M, Tamburlini G. Components of acellular pertussis vaccines. Lancet 1996;347: 764-765. Italian Collaborative Group on Preterm Delivery (ICGPD). Vitamin A supplementation in premature neonates with postnatal lung injury. Int J Clin Pharm Ther 1996;34:362-365. 1997 Bonati M, Bosetti C, Ferraro R, Miglio D, Sanvito E, Violante A. The Southern Italy Neonatal Intensive Care Units Network: very low birth-weight outcomes for 1994. J Epidemiol Biostat 1997;2:171-178. Campomori A, Bonati M. Fluconazole treatment for vulvovaginal candidiasis during pregnancy. Ann Pharmacother 1997;31:118-119. Impicciatore P, Nannini S, Pandolfini C, Bonati M. Mothers' knowledge, attitudes toward, and management of fever in preschool children in Italy. Prev Med 1998;27:268-273. Impicciatore P, Pandolfini C, Casella N, Bonati M. Reliability of public-oriented health care resources on the World Wide Web the home management of fever in children. BMJ 1997;314:1875-1881. Impicciatore P, Violante A, Bonati M. Helping parents to cope when their preschool children are acutely ill. BMJ 1997;314:373. Bailey B, Addis A, Lee A, Sanghvi K, Mastroiacovo P, Mazzone T, Bonati M, Paolini C, Garbis H, Val T, De Souza CFM, Matsui D, Schechtman AS, Conover B, Lau M, Koren G. Cisapride use during human pregnancy: a prospective, controlled multicenter study. Digest Dis Sci 1997;42(9):1848-1852. Barbui C, Campomori A, Bonati M. Clozapine and blood dyscrasias different from agranulocytosis. Can J Psychiat 1997;42:981-982. Barbui C, Campomori A, Bonati M. Clozapine and non-granulocyte blood dyscrasias. BODHY 1997;18:120-121.

Zullini MT, Bonati M, Sanvito E, Paulista Collaborative Group on Neonatal Care. Survival in neonatal intensive care units. A survey of nine centers in São Paulo, Brazil. Revista Panamericana de Salud Publica 1997;2(5):303-309. 1998 Bonati M, Addis A. Informing women about drugs they take during pregnancy: promoting consumers drug information as integral part of care. Pharm World Sci 1998;20:236-237. Bonati M, Impicciatore P, Pandolfini C. Quality on the Internet. BMJ 1998;317:1501. Lalkin A, Loebstein R, Addis A, Ramezani-Namin F, Magee LA, Mastroiacovo P, Mazzone T, Vial T, Bonati M, Koren G. The safety of omeprazole during pregnancy: a multi-center prospective controlled study. Am J Obstet Gynaecol 1998;179:727-730. Impicciatore P, Nannini S, Pandolfini C, Bonati M. Mothers' knowledge, attitudes toward, and management of fever in preschool children in Italy. Prev Med 1998;27:268-273. Impicciatore P, Pandolfini C, Bosetti C, Bonati M. Adverse drug reactions in children: a systematic review of published case reports. Paediatr Perinatal Drug Ther 1998;2:27-36. Loebstein R, Addis A, Ho E, Andreou R, Sage S, Donnenfeld A, Schick B, Bonati M, Moretti M, Lalkin A, Pastuszak A, Koren G. Pregnancy outcome following gestational exposure to fluoroquinolones: a multicenter prospective controlled study. Antimicrob Agents Chemother 1998;42:1336-1339. Marraro G, Bonati M, Ferrari A, Barzago MM, Pagani C, Bortolotti A, Galbiati A, Luchetti M, Croce A. Perfluorocarbon broncho-alveolar lavage and liquid ventilation versus saline broncho-alveolar lavage in adult guinea pig experimental model of meconium inhalation. Intens Care Med 1998;24:501-508. 1999 Addis A, Bonati M. Use of nimesulide in children. Lancet 1999;354:1034. Bonati M, Choonara I, Hoppu K, Pons G, Seyberth H. Closing the gap in drug therapy. Lancet 1999;353:1625. Loebstein R, Lalkin A, Addis A, Costa A, Lalkin I, Bonati M, Koren G. Pregnancy outcome after gestational exposure to terfenadine: A multicenter, prospective controlled study. Journal Allergy Clinical Immunology 1999;104:953-956. Mastroiacovo P, Mazzone T, Addis A, Elephant E, Carler P, Garbis H, Robert E, Bonati M, Ornory A, Finardi A, Schaffer C, Caramelli L, Rodriguez Pinilla E, Clementi M. High Vitamin A intake in early pregnancy and congenital malformations: a multicentre prospective controlled study. Teratology 1999;59:7-11. 2000 Addis A, Sharabi S, Bonati M. Risk classification systems of drug use during pregnancy. Are they a reliable source of information? Drug Safety 2000;23:245-253. Autret E, Bonati M, Choonara I, Gorodischer R, Guignard JP, Hoppu K, Jackz-Aigrain E, Pons G, Rane A, Seyberth H, van den Anker J. Medicines for Children. Paediatr Perinatal Drug Ther 2000;4:23. Bonati M. Primary care is natural place for clinical research and practice. BMJ 2000;321:1529. Bonati M. The cry of an intellectual. BMJ.com 2000; www.bmj.com/cgi/iletters/320/7244/1283.

Bonati M. Why such diverse prices of infant formula in Europe? Lancet 2000;355:321-322. Bonati M, Campi R. Breastfeeding and Infant Illness. Am J Public Health 2000;90:1478. Bonati M, Impicciatore P, Pandolfini C. Register of clinical trials in children must be set up. BMJ 2000;320:1339-1340. Conroy S, Choonara I, Impicciatore P, Mohn A, Arnell H, Rane A, Knoeppel C, Seyberth H, Pandolfini C, Raffaelli MP, Rocchi F, Bonati M, Jong G, de Hoog M, van den Anker J. Survey of unlicensed and off label drug use in paediatric wards in European countries. BMJ 2000;320:79-82. Pandolfini C, Impicciatore P, Bonati M. Parents on the Web: Risks for quality management of cough in children. Pediatrics 2000;105:1-8. Impicciatore P, Bosetti C, Schiavio S, Pandolfini C, Bonati M. Mothers as Active Partners in the Prevention of Childhood Diseases: Maternal Factors Related to Immunization Status of Preschool Children in Italy. Preventive Medicine 2000;31:49-55. Impicciatore P, Pandolfini C, Bonati M. Database could give children safer medicines. Nature 2000;405:882. Tamburlini G, Marolla L, Bonati M. Italian paediatric association has launched code on competing interests. BMJ 2000;320:382-383. Yousif NH, Bonati M. North and South: bridging the information gap. Lancet 2000;356:1034-1035. 2001 Bonati M. An Italian View. Paediatr Perinatal Drug Ther 2001;4:128. Bonati M, Clavenna A, Rocchi F, Impicciatore P Use of niflumic acid in children. Arch Dis Child (eletters) 2001;8 november. Bonati M, Impicciatore P, Pandolfini C. Evidence and belief in attention deficit hyperactivity disorder. Reintroduction of methylphenidate in Italy needs careful monitoring. BMJ 2001;322:556. Bonati M, Impicciatore P, Pandolfini C. Medicines for Children in Europe at the Beginning of the New Millenium. Paediatr Perinat Drug Ther 2001;4:82-84. Bonati M, Rocchi F, Pirola M. Electrocardiography first for reducing cot death. Lancet 2001;357:889. Bonati M, Rocchi F, Pirola M. Electrocardiography first for reducing cot death. (Author's replay). Lancet 2001;358:673. Cazzato T, Pandolfini C, Campi R, Bonati M, and the ACP Puglia-Basilicata Working Group. Drug prescribing in out-patient children in Southern Italy. Eur J Clinl Pharm 2001;57:611-616. Impicciatore P, Choonara I, Clarkson A, Provasi D, Pandolfini C, Bonati M. Incidence of adverse drug reactions in pediatric in/out-patients: a systematic review and meta-analysis of prospective studies. Br J Clin Pharm 2001;52:77-83. Rocchi F, Raffaelli MP, Marelli G, Taddei GC, Bonati M and Paediatrician Work Group of the Ospedali Riuniti Bergamo Prospective surveillance of extemporaneous dispensing of medicines for children. Paediatr Perinat Drug Ther 2001;4:152-155. 2002 Bonati M, Pandolfini C. Off-label prescribing to children in primary care. BMJ.com 2002; http://bmj.com/cgi/eletter.

Bonati M, Pandolfini C, Choonara I, Jacqz-Aigrain E, Arnau J. Something is finally moving, at least in the paediatric field... BMJ.com 2002; http://bmj.com/cgi/eletters/325/7376/1314. Campi R, Garattini L, Tediosi F, Bonati M. Pharmacoeconomics analysis of prescriptions in italian paediatric general practice. Eur J Health Econom(HEPAC) 2002;3:261-266. Clavenna A, Pandolfini C, Bonati M. Public disclosure of clinical trials in children. Curr Ther Res 2002;63:707-716. Impicciatore P, Mohn A, Chiarelli F, Pandolfini C, Bonati M Adverse drug reactions to off-label drugs on a paediatric ward:an Italian prospective pilot study. Paed Perin Drug Thery 2002;5:19-24. Pandolfini C, Bonati M. Follow up of quality of public oriented health information on the world wide web: systematic re-evaluation. BMJ 2002;324:582-583. Pandolfini C, Impicciatore P, Provasi D, Rocchi F, Campi R, Bonati M, Italian Paediatric Off-label Collaborative Group. The off-label use of drugs in Italy: a prospective, observational, multicentre study. Acta Paed 2002;91:339-347. Ricci E, Parazzini F, Motta T, Ferrari CI, Colao A, Clavenna A, Rocchi F, Gangi E, Paracchi S, Gasperi M, Nicolosi AE, Ferrero S, Landi ML, Beck-Peccoz P, Bonati M. Pregnancy outcome after cabergoline treatment in early weeks of gestation. Reprod Toxicol 2002;16:791-793. 2003 Bonati M. Why diverse prices of infant formula in Europe never seems harmonised. BMJ.com 2003; http://bmj.com/cgi/eletters/326/7396/984;2003. Clavenna A, Rossi E, Berti A, Pedrazzi G, De Rosa M, Bonati M and the ARNO Working Group. Inappropriate use of anti-asthmatic drugs in the Italian paediatric population. Eur J Clin Pharmacol 2003;59:565-569. Pandolfini C, Bonati M. Off-Label drug use in children in Europe: a major health issue. Pharm Dev Regul 2003;1:133-143. Pandolfini C, Bonati M, Reggi V, Figueras A. Regulatory assessment of new drugs in developing countries. Lancet 2003;362:249-250. Pandolfini C, Bonati M, Sammons H, Choonara I, Jacqz-Aigrain E, Danès I, Arnau J. A european clinical trials registry for children. Paediatr Perin Drug Ther 2003;5:98-100. The international comparative study on drug information (ICSODI) collaborative group. Prescribing information in 26 countries: a comparative study. Eur J Clin Pharmacol 2003;59:263-270. 2004 Bonati M, Campi R. Regional inequalities in health for Italian children. Global Health Watch Webside 2004 http://www.ghwatch.org/english/casestudies/ghw_italy.pdf. Bonati M, Pandolfini C. Is it time for an European Formulary of Paediatric Medicines? Arch Dis Childhood 2004;89:890-891. Bonati M, Pandolfini C. Children need international formulary to guarantee rational use of drugs. BMJ.com 2004;328:227. Bonati M, Pandolfini C, Clavenna A. Disclosure of Clinical Trials in Children. Science 2004;305:1401.

Bonati M, Pandolfini C, Rossi V, Santoro E, Arnau De Bolos JM, Carreras ID, Camps IF, Castel Llobet JM, Jacqz-Aigrain E, Zarrabian S, Choonara I, Sammons H, Steingo J. Launch of a European paediatric clinical trials register. Paed Perin Drug Ther 2004;6:38-39. Bonati M, Pandolfini C, Rossi V, Santoro E, Arnau JM, Fuentes I, Castel Llobet JM, Jacqz-Aigrain E, Zarrabian S, Choonara I, Sammons H, Steingo J. Public disclosure of clinical trials. BMJ.com (e-letter) 2004; bmj.bmjjournals.conm/cgi/eletters/329/7457/64#69125. Bonati M, Pandolfini C. A complete clinical trial register is already a reality for the paediatric field. BMJ (e-letter) 2004 http://bmj.bmjjournals.com/cgi/eletters/329/7467/637#90155. Cavazza A, Tagliabue P, Fedeli T, Investigators of the Italian Group of Neonatal Pneumology, Bonati M. Impact of Chronic Lung Disease on very low birth weight infants: a collaborative study of the Italian Group of Neonatal Pneumology. Ital J Pediatr 2004;30:393-400. Clavenna A, Bonati M, Rossi E, De Rosa M. Increase in non-evidence based use of antidepressants in children is cause for concern. BMJ 2004;328:711-12. Hutangkabodee S, Krisanaphan C, Reggi V, Figueras A, Bonati M. Regulatory evaluation of efficacy and safety of new drugs in China. J Med Assoc Thai 2004;87:1135. Marchetti F, Ronfani L, Conti Nibali S, Bonati M, Tamburlini G, for Italian Study Group on Acute Otitis Media Restricted indications for the use of antibiotics in acute otitis media. Eur J Clin Pharmacol 2004;60:293-294. Panei P, Arcieri R, Vella S, Bonati M, Martini N, Zuddas A. Italian Attention-Deficit/Hiperactivity Disorder Registry. Pediatrics 2004;114:514. Schiavetti B, Clavenna A, Campi R, Bonati M. NSAIDs during pregnancy and risk of miscarriage: true risks or only suspicions? BMJ 2004;328:108-9. Zhang XL, Bertelé V, Reggi V, Bonati M. Regulatory evaluation of efficacy and safety of new drugs in China. Chinese Medical Journal 2004;117:320. 2005 Bonati M, Campi R. What Can We Do to Improve Child Health in Southern Italy? PLos Medicine 2005;2(9):e250. Bonati M, Clavenna A. The epidemiology of psychotropic drug use in children and adolescents. International Review of Psychiatry 2005;17:181-188. Bonati M, Pandolfini C. More on compulsory registration of clinical trials. BMJ 2005;330:480. Bonati M, Pandolfini C. Pediatric clinical trials registry. CMAJ 2005;172:1159-1160. Pandolfini C, Bonati M. A literature review on off-label drug use in children. Eur J Ped 2005;164:552-558.ff Bonati M, Pandolfini C, Rossi V, Santoro E, Arnau JM, Fuentes I, Carreras ID, Camps IF, Castel Llobet JM, Jacqz-Aigrain E, Zarrabian S, Choonara I, Sammons H, Steingo J, Naylor C. A complete clinical trial register is already a reality for pediatric field. CMAJ (e-letters) 2005; http://www.cmaj.ca/cgi/eletters/171/6/606. Pandolfini C, Campi R, Clavenna A, Cazzato T, Bonati M. Italian paediatricians and off-label prescriptions: loyal to regulatory or guideline standards? Acta Paed 2005;94:753-757.

Sammons HM, Naylor C, Choonara I, Pandolfini C, Bonati M. Should paediatricians support the European Paediatric Clinical Trials Register? Arch Dis Child 2005;90:559-560. 2006 Bonati M, Clavenna A, Rossi E, De Rosa M. Antidepressant prescribtions in children and adolescents in general practice. BMJ.com 2006; http://bmj.bmjjournals.com/cgi/eletters/331/7530/1451#125977. Bonati M, Breitkreutz J, Choonara I, Hoppu K, Jacqz-Aigrain E, Langhendries JP, Pons G, Rane A, Seyberth H, van den Anker J on behalf of the ENDIC. Paediatric Clinical Pharmacology in Europe. Paed Perin Drug Ther 2006;7:134-37. Bonati M, Maschi S, Clavenna A. Differences in generic sertraline for children: real or artefact. Eur J Clin Pharmacol 2006;62:1083-85. Bonati M, Pandolfini C. Trial registration, the ICMJE statement, and paediatric journals. Arch Dis Child 2006;91:93. Bonati M, Pandolfini C. Trial registration, the International Committee of Medical Journals Editors statement, and paediatric journals. Pediatr Anesth 2006;16:92-99. Bonati M, Pandolfini C, Rossi V, santoro E, Arnau de Bolos JM, Danes Carreras I, Fuentes Camps I, Castel Llobet JM, Jacqz-Aigrain E, Zarrabian S, Choonara I, Sammons H, Smith C. Registering paediatric clinical trials. Paed Perin Drug Ther 2006;7:170-171. Santoro E, Rossi, V, Pandolfini C, Bonati M. DEC-net: the development of the European Register of Clinical Trials on Medicines for Children. Clinical Trials 2006;3:366-375. Varona Rodriquez F, Bonati M, Rdeder M, Choonara I. Health care in Cuba. Lancet.com 2006; http://www.thelancet.com/journals/lancet/article/piis014067360669171x/comments?page=2&prev=1 &totalcomments=3#645. 2007 Arias G, Palau M, Perez M, Bonati M. Philanthropic prize to remember that Latin American Children s health is a priority. Pan American Journal of Public Health (Revista Panamericana de Salud Publica) 2007;22:294. Campi R, Bonati M. Italian child health statistic review: births and deaths. Ital J Ped 2007;33:67-73. Campi R, Bonati M. Italian child health statistic review: morbidity and social habits. Ital J Ped 2007;33:144-149. Clavenna A, Bonati M. Antidepressant prescriptions in the outpatient childhood population in Europe. Paediatr Perin Drug Ther 2007;8:103-8. Clavenna A, Rossi E, De Rosa M, Bonati M. Use of Psychotropic Medications in Italian Children and Adolescents. Eur J Pediatr 2007;166:339-47. Choonara I, Bonati M. European legislation to improve medicines for children. Paedat Perin Drug Ther 2007;8:2-3. Marchetti F, Bua J, Ventura A, Notarangelo LDE, Di Maio S, Migliore G, Bonati M. The awareness among paediatricians of off-label prescribing in children: a survey in Italian Hospitals. Eur J Clin Pharmacol 2007;63:81-85.

Rossignoli A, Clavenna A, Bonati M. Antibiotic prescription and prevalence rate in the outpatient pediatric population: analysis of surveys published during 2000-2005. Eur J Clin Pharmacol 2007;63:1099-106. 2008 Bonati M. An independent contribution to the growth of paediatric clinical pharmacology in Italy. Eur J Clin Pharmacol 2008;64:343-346. Clavenna A, Bonati M. A missed opportunity. BMJ http://www.bmj.com/cgi/eletters/337/nov24_2/a2245#205527:2008. Font M, Miselli M, Conforti A, Bonati M. An Italian Story with wider implications? BMJ http://www.bmj.com/cgi/eletters/336/7655/1208-b#200313:2008. Maschi S, Clavenna A, Schiavetti B, Campi R, Bernat M, Bonati M. Neonatal outcome following pregnancy exposure to antidepressants: a prospective controlled cohort study. BJOG 2008;115:283-289. Pandolfini C, Bonati M. European paediatric research and children s therapeutic needs. A trial review. Acta Paediatrica 2008;97:1232-1237. Pandolfini C, Bonati M. Something is moving in European drug research for children, but a more focused effort concerning all therapeutic needs is mandatory. Arch Dis Child 2008;93:715. Pandolfini C, Bonati M, Rossi V, Santoro E, Choonara I, Naylor C, Sammons E, Jacqz-Aigrain E, Zarrabian S, Arnau JM, Castel JM, Danés I, Fuentes I. The DEC-net European register of paediatric drug therapy trials: contents and context. Eur J Clin Pharmacol 2008;64:611-617. Santos DB, Clavenna A, Bonati M, Coelho HL. Off-label and unlicensed drug utilization in hospitalized children in Fortaleza, Brazil. Eur J Clin Pharm 2008;64:1111-18. Usala T, Clavenna A, Zuddas A, Bonati M. Randomised controlled trials of Selective Serotonin Reuptake Inhibitors in treating depression in children and adolescents: a systematic review and metaanalysis. European Neuropsychopharmacology 2008;18:62-73. 2009 Bianchi M, Clavenna A, Labate L, Bortolotti A, Fortino I, Merlino L, Locatelli WG, Giuliani G, Bonati M. Anti-asthmatic drug prescriptions to an Italian paedriatic population. Pediatric Allergy Immunology 2009;20:585-591. Bonati M. Once again, children are the main victims of fake drugs. Arch Dis Child 2009;94:468. Bonati M, Garattini S. Controlling Cervical Cancer. PharmacoEconomics 2009;27:91-93. Campi R, Barbato A, D Avanzo B, Guaiana G, Bonati M. Suicide in Italian children and adolescents. Journal of Affective Disorders 2009;113:291-295. Clavenna A, Berti A, Gualandi L, Rossi E, De Rosa M, Bonati M. Drug utilisation profile in the Italian paediatric population. Eur J Pediatr 2009;168:173-180. Clavenna A, Bonati M. Adverse drug reactions in childhood: a review of prospective studies and safety alerts. Arch Dis Child 2009;94:724-728. Clavenna A, Bonati M. Drug prescriptions to outpatient children: a review of the literature. Eur J Clin Pharmacol 2009;65:749-755.

Clavenna A, Sequi M, Bortolotti A, Merlino L, Fortino I, Bonati M. Determinants of the drug utilisation profile in the paediatric population in Italy s Lombardy Region. Br J Clin Pharmacol 2009;67:565-571. Fortinguerra F, Clavenna A, Bonati M. Psychotropic drug use during breastfeeding: a review of the evidence. Pediatrics 2009;124:e547-e556. Pandolfini C, Bonati M. Children s presence in research. A review of online registers. Eur J Clin Pharmacol 2009;65:873-880. Pandolfini C, Bonati M, Sammons HM. Registration of trials in children. Update of current international initiatives. Arch Dis Child 2009;94:717-719. Pandolfini C, Clavenna A, Bonati M. Quality of cystic fibrosis information on Italian websites. Informatics Health Social Care 2009;34:10-17. 2010 Bianchi M, Clavenna A, Bonati M. Inter-country variations in anti-asthmatic drug prescriptions for children. Systematic review of studies published during the 2000-2009 period. Eur J Clin Pharmacol 2010;66:929-36. Bonati M. Commentary: Recurrence of bipolar spectrum disorders. A common issue among the affected population of young people. Evidence-Based Mental Health 2010;13:43. Bonati M, Pandolfini C. Safety of ciprofloxacin in neonates with sepsis. Adverse Drug Reactions Bulletin 2010;n.265:1019-22. Clavenna A, Pandolfini C, Bianchi M, Bonati M. Do children really need more research on respiratory drugs? Acta Paeditr 2010;99:1445-46. Clavenna A, Sequi M, Bonati M. Drug prescribing by Italian family paediatricians: an exception? Acta Paediatr 2010;99:754-757. Clavenna A, Sequi M, Bonati M. Differences in the drug prescriptions to children by Italian paediatricians and general practitioners. Eur J Clin Pharmacol 2010;66:519-524. Fortinguerra F, Maschi S, Clavenna A, Bonati M. Pain management in the paediatric population. The regulatory situation in Europe. Arch Dis Child 2010;95:749-753. Panei P, Arcieri R, Bonati M, Bugarini M, Didoni A, Germinario E. Safety of psychotropic drug prescribed for attention-deficit/hyperactivity disorder in Italy. Adverse Drug Reaction Bulletin 2010;260:999-1002. 2011 Bianchi M, Campi R, Bonati M. Smoke-free legislation and hospitalizations for childhood asthma. N Engl J Med 2011;364:87-88. Bianchi M, Clavenna A, Sequi M, Bonati M. Infant antibiotic use and asthma risk: the chicken or the egg causality dilemma. Pediatrics http://pediatrics.aappublications.org/content/127/6/1125/ reply#pediatrics_el_51443: 2011. Bianchi M, Clavenna A, Sequi M, Bonati M. Asthma diagnosis VS. analysis of anti-asthmatic prescriptions to identify asthma in children. Eur J Clin Pharmacol 2011;67:967-68.